✦ LIBER ✦

Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease

✍ Scribed by M.H.A. RUSTIN; I.B. KOVACS; S.O. SOWEMIMO-COKER; P.J. MADDISON; J.D.T. KIRBY

Book ID: 108658849
Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 465 KB
Volume: 113
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.1985.tb02077.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nifedipine in the treatment of Raynaud's

Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis

✍ R.H.MEYRICK THOMAS; M. RADEMAKER; S.M. GRIMES; A. MACKAY; I.B. KOVACS; E.D. COOK 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB

Clinical implications from capillaroscop

Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis

✍ Ariane L. Herrick; Maurizio Cutolo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

Blood flow changes with naftidrofuryl in

Blood flow changes with naftidrofuryl in systemic sclerosis and Raynaud's phenomenon

✍ P. M. GAYLARDE; O. T. TAN; I. SARKANY 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

Sublingual and oral isoxsuprine in patie

Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon

✍ H. Wesseling; A. Heeten; A. A. Wouda 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 524 KB

Antioxidant status after iloprost treatm

Antioxidant status after iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis

✍ Alexandra Balbir-Gurman; Yolanda Braun-Moscovici; Vladimir Livshitz; Daniel Scha 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 111 KB

Infrequency of anticentromere antibody i

Infrequency of anticentromere antibody in patients without systemic sclerosis and without Raynaud's phenomenon

✍ Sergio Migliaresi; Ugo Picillo; Giuseppe Tirri; Raffaele D. G. Improta; Francesc 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 2 views